VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,844 | -63.2% | 63,057 | -3.7% | 0.00% | -100.0% |
| Q2 2023 | $1,606,077 | +3.0% | 65,474 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $1,559,462 | -42.4% | 67,016 | -37.3% | 0.00% | 0.0% |
| Q4 2022 | $2,707,259 | +34.1% | 106,964 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $2,019,000 | -25.0% | 104,707 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $2,691,000 | -0.5% | 105,665 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $2,704,000 | +161.8% | 105,128 | +421.7% | 0.00% | – |
| Q1 2021 | $1,033,000 | -27.9% | 20,152 | -62.3% | 0.00% | – |
| Q4 2020 | $1,432,000 | +16.7% | 53,487 | +49.6% | 0.00% | – |
| Q3 2020 | $1,227,000 | – | 35,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |